GHRP-6 is a synthetic hexapeptide ghrelin / GHS-R1a receptor agonist the historic prototype that established the GH-releasing peptide class
This product is distributed strictly as a non-medical research material and is not intended for human or veterinary use
Seier, S., Stamp-Larsen, K., Jensen, S
Comprehensive obesity and diabetes management extends beyond pharmacotherapy, incorporating medical nutrition therapy, physical activity (150 minutes weekly of moderate-intensity exercise), behavioral counseling, and treatment of comorbidities
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage
[DOI] [PubMed] [Google Scholar] Neubauer C, Yamamoto HY